Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
Wiegand J, Wedemeyer H, Franke A, Rößler S, Zeuzem S, Teuber G, Wächtler M, Römmele U, Ruf B, Spengler U, Trautwein C, Bock CT, Fiedler GM, Thiery J, Manns MP, Brosteanu O, Tillmann HL; German Hep-Net Acute Hepatitis B (GAHB) Study Group.
Wiegand J, et al.
J Viral Hepat. 2014 Oct;21(10):744-50. doi: 10.1111/jvh.12210. Epub 2013 Dec 11.
J Viral Hepat. 2014.
PMID: 24329913
Clinical Trial.